Circulating OPN levels increase in states of metabolic dysfunction such as obesity, diabetes, and NAFLD, and is thought to mediate, at least in part, their associated cardiovascular complications [358]. This evidence concerns the gene SPP1 and obesity due to melanocortin 4 receptor deficiency.